Eli Health, the company behind the Hormometer instant hormone monitoring system, will launch an at-home progesterone test in February 2026. The test uses a saliva sample and delivers results to a smartphone app without laboratory processing.
The progesterone test follows the company’s cortisol monitoring launch in October 2025 and a testosterone test, which will also launch in February. All three tests use the same Hormometer device and saliva-based sampling method.
Progesterone plays a key role in the menstrual cycle, fertility, and pregnancy. Levels fluctuate throughout the cycle and can indicate whether ovulation has occurred. Traditional lab tests for progesterone typically require blood draws and can take days for results, making it difficult to track patterns across a cycle.
Eli Health was founded by Marina Pavlovic Rivas and Thomas Cortina and is based in New York. The company closed a $12 million Series A funding round in June 2025 led by BDC Capital’s Thrive Venture Fund and has raised $20 million to date. The company completed over five years of research and development, securing 12 patent-pending innovations across biochemistry, hardware, software, and artificial intelligence.
The Hormometer device has FDA registration and results are validated against ELISA, a gold-standard hormone testing method.
